SLCO1B3 and hepatocellular carcinoma: Survival analysis indicated a trend in shorter overall survival with low gene expression of SLCO1B3 in HCC patients; however, there was no significant correlation between SLCO1B3 gene expression and the survival rates (p = 0.2).